ScholarGate
Avustaja

Vertaile menetelmiä

Tarkastele valitsemiasi menetelmiä rinnakkain; eroavat rivit korostetaan.

PedsQL-sikkelisolu anemian moduuli×PedsQL Cancer Module×
TieteenalaLastenlääketiedeLastenlääketiede
MenetelmäperheProcess / pipelineProcess / pipeline
Syntyvuosi20122002
KehittäjäJames W. VarniJames W. Varni
TyyppiChild self-report and parent proxyChild self-report and parent proxy
AlkuperäislähdeVarni, J. W., Limbers, C. A., Bryant, W. P., & Wilson, D. P. (2012). The PedsQL in pediatric sickle cell disease: Measurement model, factor structure, and reliability and validity of the pediatric quality of life inventory sickle cell disease module. Journal of Health Psychology, 17(7), 1012-1024. link ↗Varni, J. W., Burwinkle, T. M., Katz, E. R., Meeske, K., & Dickinson, R. P. (2002). The PedsQL in pediatric cancer: Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, multidimensional fatigue scale, and cancer module. Cancer, 94(7), 2090-2106. DOI ↗
RinnakkaisnimetPedsQL 3.0 Sickle CellPedsQL 3.0 Cancer
Liittyvät45
TiivistelmäThe PedsQL Sickle Cell Disease Module is a disease-specific instrument developed by Varni et al. in 2012 to measure quality of life in children and adolescents with sickle cell disease aged 2–18 years. Measuring across domains including pain and symptoms, functional limitations, school impact, and disease-related worry, it captures how sickle cell disease and its complications affect daily life and well-being. Used alongside the PedsQL Generic Core Scales, it provides comprehensive assessment of sickle cell disease-specific and general health-related quality of life.The PedsQL Cancer Module is a 31-item disease-specific instrument developed by Varni et al. in 2002 to measure quality of life in children and adolescents with cancer aged 2–18 years. It captures treatment burden (nausea, vomiting, pain, hair loss), cancer-related worry, cognitive concerns, and emotional and social impacts of diagnosis and treatment. Used alongside the PedsQL Generic Core Scales, it provides comprehensive assessment of both cancer-specific and general health-related quality of life during active treatment, survivorship, and end-of-life care.
ScholarGateAineisto
  1. v1
  2. 2 Lähteet
  3. PUBLISHED
  1. v1
  2. 2 Lähteet
  3. PUBLISHED

Siirry hakuun Lataa diat

ScholarGateVertaile menetelmiä: PedsQL Sickle Cell Module · PedsQL Cancer Module. Haettu 2026-06-20 osoitteesta https://scholargate.app/fi/compare